Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Am J Cardiol. 2021 Feb 2;146:15–21. doi: 10.1016/j.amjcard.2021.01.017

Table 2.

Association of sACE2 with hs-cTnI, hs-cTnT, and NT-proBNP as continuous variables (ln transformed) at ARIC visit 5

Biomarker Model Beta-coefficient* 95% CI p-value
ln–hs-cTnI 1 0.27 0.16–0.39 <0.001
2 0.25 0.13–0.36 <0.001
ln–hs-cTnT 1 0.15 0.08–0.23 <0.001
2 0.15 0.08–0.22 <0.001
ln–NT-proBNP 1 0.33 0.18–0.48 <0.001
2 0.29 0.14–0.44 <0.001
*

Increment in hs-cTnI, hs-cTnT, or NT-proBNP (log unit) per log unit increase of sACE2, where sACE2 is independent and hs-cTnI, hs-cTnT, or NT-proBNP the dependent variables.

Model 1: adjusted by visit 5 age, sex, and race; model 2: model 1 plus visit 5 total cholesterol, HDL-C, SBP; use of antihypertension medication, current smoking, diabetes status, use of lipid-lowering medication, prevalent CVD, and eGFR.